Differential cell cycle response of nontumorigenic and tumorigenic human papillomavirus-positive keratinocytes towards transforming growth factor-β1

Journal of Molecular Medicine

Volumn 78, Issue 2, 2000, Pages 94-101

  Hasskarl, Jens ^a,c   Butz, Karin ^a   Whitaker, Noel ^a   Ullmann, Angela ^a   Dürst, Matthias ^b   Hoppe Seyler, Felix ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b JENA UNIVERSITY HOSPITAL   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Cell cycle; Cervical cancer; Human papillomavirus; Transforming growth factor beta; Tumor virus

Indexed keywords

PROTEIN P21; PROTEIN P53; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CELL CYCLE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; KERATINOCYTE; REGULATOR GENE; VIRUS CARCINOGENESIS; WART VIRUS;

EID: 0034079226     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001090000083     Document Type: Article

References (39)

1. 1. zur Hausen H (1996) Papillomavirus infections - a major cause of human cancers. Biochim Biophys Acta 1288:F55-F78
2. 2. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM (1990) The E6 oncoprotein encoded by human papillomavirus type 16 and 18 promotes the degradation of p53. Cell 63:1129-1136
3. 3. Boyer SN, Wazer DE and Band V (1996) E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res 56:4620-4624
4. CIP1-mediated inhibition of cdk2. Genes Dev 11:2101-2111
5. 5. Bascom CC, Sipes NJ, Coffey RJ, Moses HL (1989) Regulation of epithelial cell proliferation by transforming growth factors. J Cell Biochem 39:25-32
6. 6. Markovitz SD, Roberts AB (1996) Tumor suppressor activity of the TGFβ pathway in human cancers. Cytokine Growth Factor Rev 7:93-102
7. 7. Woodworth CD, Notario V, DiPaolo JA (1990) Transforming growth factors beta 1 and 2 transcriptionally regulate human papillomavirus (HPV) type 16 early gene expression in HPV-immortalized human genital epithelial cells. J Virol 64:4767-4775
8. 8. Ozbun M, Meyers C (1996) Transforming growth factor β1 induces differentiation in human papillomavirus-positive keratinocytes. J Virol 70:5437-5446
9. 9. Braun L, Dürst M, Mikumo R, Gruppuso P (1990) Differential response of nontumorigenic and tumorigenic human papillomavirus type 16-positive epithelial cells to transforming factor β1. Cancer Res 50:7324-7332
10. 10. Pietenpol JA, Stein RW, Moran E, Yaciuk P, Schlegel R, Lyons RM, Pittelkow MR, Münger K, Howley PM, Moses HL (1990) TGF-β-1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRb binding domains. Cell 61:777-785
11. 11. Dürst M, Dzarlieva-Petrusevska RT, Boukamp P, Fusenig NE, Gissmann, L, (1987) Molecular and cytogenetic analysis of immortalized human primary keratinocytes obtained after transfection with human papillomavirus 16. Oncogene 1:251-256
12. 12. Seagon S, Dürst M (1994) Genetic analysis of an in vitro model system for human papillomavirus type 16-asociated carcinogenesis. Cancer Res 54:5593-5598
13. 13. Dürst M, Seagon S, Wanschura S, zur Hausen H, Bullerdiek J (1995) Malignant progression of an HPV16-immortalized human keratinocyte cell line (HPKIA) in vitro. Cancer Genet Cytogenet 85:105-112
14. 14. Nees M, van Wijngaarden E, Bakos E, Schneider A, Dürst M (1998) Identification of novel molecular markers which correlate with HPV-induced tumor progression. Oncogene 16: 2447-2458
15. INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature 371:257-261
16. KIP1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev 8:9-22
17. 17. Datto MB, Li Y, Panus JF, Howe DJ, Xiong Y, Wang X-F (1995) Transforming growth factor β induces the cyclin-dependent inhibitor p21 through a p53-independent mechanism. Proc Natl Acad Sci USA 92:5545-5549
18. 18. Laiho M, DeCaprio JA, Ludlow JW, Livingston DM, Massagué J (1990) Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation. Cell 62:175-185
19. 19. Butz K, Shahabeddin L, Geisen C, Spitkovsky D, Ullmann A, Hoppe-Seyler F (1995) Functional p53 protein in human papillomavirus-positive cancer cells. Oncogene 10:927-936
20. 20. Chen C, Okayama H (1987) High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 7:2745-2752
21. 21. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer E, Kinzler KW, Vogelstein B (1993) WAF-1, a potential mediator of p53 tumor suppression. Cell 75:817-825
22. 22. Hoppe-Seyler F, Butz K, zur Hausen H (1991) Repression of the human papillomavirus type 18 enhancer by the cellular transcription factor Oct-1. J Virol 65:5613-5618
23. 23. Chomczynski P, Sacchi N (1987) Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159
24. WAF1/CIP1/SDI1 mRNA and protein expression upon genotoxic stress. Oncogene 17:781-788
25. 25. Whitaker NJ, Bryan TM, Bonnefin P, Chang AC-M, Musgrove EA, Braithwaite AW, Reddel RR (1995) Involvement of RB-1, p53, p16INK4, and telomerase in immortalisation of human cells. Oncogene 11:971-976
26. 26. Geng Y, Weinberg RA (1993) Transforming growth factor beta effects on expression of G1 cyclins and cyclin-dependent protein kinases. Proc Natl Acad Sci USA 90:10315-10319
27. 27. Herzinger T, Wolf DA, Eick D, Kind P (1995) The pRb-related protein p130 is a possible effector of transforming growth factor β1 induced cell cycle arrest in keratinocytes. Oncogene 10:2079-2084
28. 28. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach, D (1993) p21 is a universal inhibitor of cyclin kinases. Nature 366:701-704
29. 29. Weinberg RA (1995) The retinoblastoma protein and cell cycle control. Cell 81:323-330
30. 30. Kessis TD, Slebos RJ, Nelson WG, Kastan, MB, Plunkett BS, Han SM, Lorincz AT, Hedrick L, Cho KR (1993) Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage. Proc Natl Acad Sci USA 90:3988-3992
31. ARF links the tumor suppressors RB and p53. Nature 395:124-125
32. 32. Jones DL, Münger K (1996) Interaction of human papillomavirus E7 protein with cell cycle regulators. Sem Cancer Biol 7:327-337
33. 33. Creek KE, Geslani G, Batova A, Pirisi L (1995) Progressive loss of sensitivity to growth control by retinoic acid and transforming growth factor-beta at late stages of human papillomavirus type 16-initiated transformation of human keratinocytes. Adv Exp Med Biol 375:117-135
34. 34. Funk JO, Waga S, Harry JB, Espling E, Stillman B, Galloway DA (1997) Inhibition of cdk activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein. Genes Dev 11:2090-2100
35. KIP1 by the human papillomavirus type 16 E7 oncoprotein. Oncogene 13:2323-2330
36. 36. Jänicke RU, Walker PA, Lin XY, Porter AG (1996) Specific cleavage of the retinoblastoma protein by an ICE-like protease in apoptosis. EMBO J 15:6969-6978
37. 37. Heldin CH, Miyazono K, ten Dijke P (1997) TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature 390:465-471
38. 38. Massagué J, Hata A, Liu, F (1997) TGF-β signalling through the Smad pathway. Trends Cell Biol 7:187-192
39. 39. Derynck R, Zhang Y, Feng X-H (1998) Smads: transcriptional activators of TGF-β responses. Cell 95:737-740